An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.
This report contains market size and forecasts of Antiemetic Drugs in global, including the following market information:
- Global Antiemetic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Antiemetic Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antiemetic Drugs companies in 2021 (%)
The global Antiemetic Drugs market was valued at 4893.3 million in 2021 and is projected to reach US$ 6556.4 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dopamine Antagonist Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antiemetic Drugs include GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi, Abbott, Bristol-Myers Squibb, Cipla, Eisai and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antiemetic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiemetic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antiemetic Drugs Market Segment Percentages, by Type, 2021 (%)
- Dopamine Antagonist
- 5-HT-3 Receptor Antagonist
- NK1 Receptor Antagonist
- Cannabinoid Receptor Antagonist
Global Antiemetic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antiemetic Drugs Market Segment Percentages, by Application, 2021 (%)
- Chemotherapy
- Gastroenteritis
- Surgery
Global Antiemetic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antiemetic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Antiemetic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Antiemetic Drugs revenues share in global market, 2021 (%)
- Key companies Antiemetic Drugs sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Antiemetic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GlaxoSmithKline
- Johnson & Johnson
- Pfizer
- Sanofi
- Abbott
- Bristol-Myers Squibb
- Cipla
- Eisai
- Eli Lilly
- Glenmark
- Helsinn Healthcare
- Heron Therapeutics
- IPCA Laboratories
- Lupin
- Merck
- Novartis
- RedHill
- Sun Pharmaceutical Industries
- Takeda Pharmaceutical
